TY - JOUR
T1 - Repeat Flow Diversion for Cerebral Aneurysms Failing Prior Flow Diversion
T2 - Safety and Feasibility From Multicenter Experience
AU - Salem, Mohamed M.
AU - Sweid, Ahmad
AU - Kuhn, Anna L.
AU - Dmytriw, Adam A.
AU - Gomez-Paz, Santiago
AU - Maragkos, Georgios A.
AU - Waqas, Muhammad
AU - Parra-Farinas, Carmen
AU - Salehani, Arsalaan
AU - Adeeb, Nimer
AU - Brouwer, Patrick
AU - Pickett, Gwynedd
AU - Ku, Jerry
AU - Yang, Victor X.D.
AU - Weill, Alain
AU - Radovanovic, Ivan
AU - Cognard, Christophe
AU - Spears, Julian
AU - Cuellar-Saenz, Hugo H.
AU - Renieri, Leonardo
AU - Kan, Peter
AU - Limbucci, Nicola
AU - Mendes Pereira, Vitor
AU - Harrigan, Mark R.
AU - Puri, Ajit S.
AU - Levy, Elad I.
AU - Moore, Justin M.
AU - Ogilvy, Christopher S.
AU - Marotta, Thomas R.
AU - Jabbour, Pascal
AU - Thomas, Ajith J.
N1 - Publisher Copyright:
© 2022 American Heart Association, Inc.
PY - 2022/4/1
Y1 - 2022/4/1
N2 - Background: Aneurysmal persistence after flow diversion (FD) occurs in 5% to 25% of aneurysms, which may necessitate retreatment. There are limited data on safety/efficacy of repeat FD-a frequently utilized strategy in such cases. Methods: A series of consecutive patients undergoing FD retreatment from 15 centers were reviewed (2011-2019), with inclusion criteria of repeat FD for the same aneurysm at least 6 months after initial treatment, with minimum of 6 months post-retreatment imaging. The primary outcome was aneurysmal occlusion, and secondary outcome was safety. A multivariable logistic regression model was constructed to identify predictors of incomplete occlusion (90%-99% and <90% occlusion) versus complete occlusion (100%) after retreatment. Results: Ninety-five patients (median age, 57 years; 81% women) harboring 95 aneurysms underwent 198 treatment procedures. Majority of aneurysms were unruptured (87.4%), saccular (74.7%), and located in the internal carotid artery (79%; median size, 9 mm). Median elapsed time between the first and second treatment was 12.2 months. Last available follow-up was at median 12.8 months after retreatment, and median 30.6 months after the initial treatment, showing complete occlusion in 46.2% and near-complete occlusion (90%-99%) in 20.4% of aneurysms. There was no difference in ischemic complications following initial treatment and retreatment (4.2% versus 4.2%; P>0.99). On multivariable regression, fusiform morphology had higher nonocclusion odds after retreatment (odds ratio [OR], 7.2 [95% CI, 1.97-20.8]). Family history of aneurysms was associated with lower odds of nonocclusion (OR, 0.18 [95% CI, 0.04-0.78]). Likewise, positive smoking history was associated with lower odds of nonocclusion (OR, 0.29 [95% CI, 0.1-0.86]). History of hypertension trended toward incomplete occlusion (OR, 3.10 [95% CI, 0.98-6.3]), similar to incorporated branch into aneurysms (OR, 2.78 [95% CI, 0.98-6.8]). Conclusions: Repeat FD for persistent aneurysms carries a reasonable success/safety profile. Satisfactory occlusion (100% and 90%-99% occlusion) was encountered in two-thirds of patients, with similar complications between the initial and subsequent retreatments. Fusiform morphology was the strongest predictor of retreatment failure.
AB - Background: Aneurysmal persistence after flow diversion (FD) occurs in 5% to 25% of aneurysms, which may necessitate retreatment. There are limited data on safety/efficacy of repeat FD-a frequently utilized strategy in such cases. Methods: A series of consecutive patients undergoing FD retreatment from 15 centers were reviewed (2011-2019), with inclusion criteria of repeat FD for the same aneurysm at least 6 months after initial treatment, with minimum of 6 months post-retreatment imaging. The primary outcome was aneurysmal occlusion, and secondary outcome was safety. A multivariable logistic regression model was constructed to identify predictors of incomplete occlusion (90%-99% and <90% occlusion) versus complete occlusion (100%) after retreatment. Results: Ninety-five patients (median age, 57 years; 81% women) harboring 95 aneurysms underwent 198 treatment procedures. Majority of aneurysms were unruptured (87.4%), saccular (74.7%), and located in the internal carotid artery (79%; median size, 9 mm). Median elapsed time between the first and second treatment was 12.2 months. Last available follow-up was at median 12.8 months after retreatment, and median 30.6 months after the initial treatment, showing complete occlusion in 46.2% and near-complete occlusion (90%-99%) in 20.4% of aneurysms. There was no difference in ischemic complications following initial treatment and retreatment (4.2% versus 4.2%; P>0.99). On multivariable regression, fusiform morphology had higher nonocclusion odds after retreatment (odds ratio [OR], 7.2 [95% CI, 1.97-20.8]). Family history of aneurysms was associated with lower odds of nonocclusion (OR, 0.18 [95% CI, 0.04-0.78]). Likewise, positive smoking history was associated with lower odds of nonocclusion (OR, 0.29 [95% CI, 0.1-0.86]). History of hypertension trended toward incomplete occlusion (OR, 3.10 [95% CI, 0.98-6.3]), similar to incorporated branch into aneurysms (OR, 2.78 [95% CI, 0.98-6.8]). Conclusions: Repeat FD for persistent aneurysms carries a reasonable success/safety profile. Satisfactory occlusion (100% and 90%-99% occlusion) was encountered in two-thirds of patients, with similar complications between the initial and subsequent retreatments. Fusiform morphology was the strongest predictor of retreatment failure.
KW - aneurysm
KW - follow-up studies
KW - humans
KW - retreatment
KW - smoking
UR - http://www.scopus.com/inward/record.url?scp=85119179151&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119179151&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.120.033555
DO - 10.1161/STROKEAHA.120.033555
M3 - Article
C2 - 34634924
AN - SCOPUS:85119179151
SN - 0039-2499
VL - 53
SP - 1178
EP - 1189
JO - Stroke
JF - Stroke
IS - 4
ER -